• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对BRCA携带者的肿瘤分析揭示了基因组的相似性,尽管时间上相隔甚远。

Tumor analysis of BRCA carriers reveals genomic similarities although separated by time.

作者信息

Falick Michaeli Tal, Granit Mizrahi Avital, Azria Batia, Maymon Ofra, Rosenberg Shai, Monin Jonathan, Braitbart Cohen Esther, Maoz Myriam, Kadiuri Luna, Nechushtan Hovav, Meyrowitz Amichay, Peretz Tamar

机构信息

Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, 91120, Jerusalem, Israel.

Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Ein Karem, 91120, Jerusalem, Israel.

出版信息

Discov Oncol. 2024 Nov 23;15(1):698. doi: 10.1007/s12672-024-01577-x.

DOI:10.1007/s12672-024-01577-x
PMID:39579167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11585525/
Abstract

Among the dominant pathogenic genes (PG) in breast cancer are BRCA1/2. Knowing whether a patient carry one of these alterations is meaningful as it affects management. A substantial question is to what extent are the genomic profile of a tumor and its characteristics affected by the germline profile of BRCA1/2 and what is the possible contribution of other environmental factors. Here, we compared the molecular characteristics of two subsequent primary breast cancers in three women (6 primary breast cancers) BRCA PG carriers, and in two of them also a primary lung cancer. Comparing two different tumors in the same patient neutralizes the contribution of other germline changes, and may demonstrate possible effects of other external insults occurring between the first and second tumor. Nonetheless, epigenetic changes resulting from early life events will be present in all tumors that the patient has developed. Our analysis suggests that tumors arising from the same tissue in the same patient share similar molecular characteristics, albeit occurring in different times, as the patient is exposed to a variety of external stimuli.

摘要

乳腺癌中主要的致病基因(PG)包括BRCA1/2。了解患者是否携带这些改变之一具有重要意义,因为这会影响治疗管理。一个重要的问题是,BRCA1/2的种系特征在多大程度上影响肿瘤的基因组特征及其特性,以及其他环境因素可能起到什么作用。在此,我们比较了三名携带BRCA致病基因的女性(6例原发性乳腺癌)中先后发生的两种原发性乳腺癌的分子特征,其中两名患者还患有原发性肺癌。比较同一患者的两种不同肿瘤可抵消其他种系变化的影响,并可能显示出在第一种肿瘤和第二种肿瘤之间发生的其他外部损伤的可能影响。尽管如此,早期生活事件导致的表观遗传变化将存在于患者所患的所有肿瘤中。我们的分析表明,同一患者同一组织中产生的肿瘤具有相似的分子特征,尽管发生在不同时间,因为患者会受到各种外部刺激。

相似文献

1
Tumor analysis of BRCA carriers reveals genomic similarities although separated by time.对BRCA携带者的肿瘤分析揭示了基因组的相似性,尽管时间上相隔甚远。
Discov Oncol. 2024 Nov 23;15(1):698. doi: 10.1007/s12672-024-01577-x.
2
Biallelic Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline Carriers.胚系致病变异携带者的非乳腺/卵巢肿瘤中存在双等位基因缺失和同源重组缺陷。
JCO Precis Oncol. 2023 Aug;7:e2300036. doi: 10.1200/PO.23.00036.
3
Genomic Profiling Comparison of Germline and Non- Carriers Reveals Amplification as a Risk Factor for Non- Carriers in Patients With Triple-Negative Breast Cancer.胚系携带者与非携带者的基因组分析比较揭示了扩增是三阴性乳腺癌患者中非携带者的一个风险因素。
Front Oncol. 2020 Oct 30;10:583314. doi: 10.3389/fonc.2020.583314. eCollection 2020.
4
Somatic variants of potential clinical significance in the tumors of phenocopies.拟表型肿瘤中具有潜在临床意义的体细胞变异。
Hered Cancer Clin Pract. 2019 Jul 16;17:21. doi: 10.1186/s13053-019-0117-5. eCollection 2019.
5
Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures.候选 BRCA 样基因中的种系和体细胞事件对乳腺癌特征的影响。
PLoS One. 2020 Sep 30;15(9):e0239197. doi: 10.1371/journal.pone.0239197. eCollection 2020.
6
Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.BRCA1和BRCA2突变携带者中早发性乳腺癌的不同分子发病机制:一项基于人群的研究。
Cancer Res. 1999 Apr 15;59(8):2011-7.
7
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
8
Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).西班牙纳瓦拉地区 BRCA 相关性遗传性乳腺癌和卵巢癌的遗传和临床特征。
BMC Cancer. 2019 Nov 27;19(1):1145. doi: 10.1186/s12885-019-6277-x.
9
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.胚系 BRCA 突变与早发性乳腺癌(POSH)的结果:一项前瞻性队列研究。
Lancet Oncol. 2018 Feb;19(2):169-180. doi: 10.1016/S1470-2045(17)30891-4. Epub 2018 Jan 11.
10
Methylation not a frequent "second hit" in tumors with germline BRCA mutations.胚系 BRCA 突变肿瘤中甲基化不是常见的“二次打击”。
Fam Cancer. 2009;8(4):339-46. doi: 10.1007/s10689-009-9240-1. Epub 2009 Apr 2.

本文引用的文献

1
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status.根据 ER 状态,BRCA1/2 携带者中存在不同的乳腺癌表型。
Breast Cancer Res Treat. 2023 Apr;198(2):197-205. doi: 10.1007/s10549-022-06851-6. Epub 2023 Feb 2.
2
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers.分析配对的原发性和复发性 BRCA1/2 突变相关肿瘤,鉴定出与复发相关的驱动因素。
Nat Commun. 2022 Nov 7;13(1):6728. doi: 10.1038/s41467-022-34523-y.
3
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
拷贝数变异作为 BRCA1/BRCA2 致病性变异携带者乳腺癌风险的修饰因子。
Commun Biol. 2022 Oct 6;5(1):1061. doi: 10.1038/s42003-022-03978-6.
4
Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study.乳腺癌幸存者的第二原发性癌症遗传风险:多民族队列研究。
Cancer Res. 2022 Sep 16;82(18):3201-3208. doi: 10.1158/0008-5472.CAN-21-4461.
5
"High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis".对携带BRCA1/2基因的高危乳腺癌患者进行筛查可实现早期诊断,并改善乳腺癌确诊后的生存率。
Front Oncol. 2021 Sep 2;11:683656. doi: 10.3389/fonc.2021.683656. eCollection 2021.
6
Biomarkers for Homologous Recombination Deficiency in Cancer.癌症中同源重组缺陷的生物标志物
J Pers Med. 2021 Jun 28;11(7):612. doi: 10.3390/jpm11070612.
7
Gene Set Knowledge Discovery with Enrichr.基因集知识发现与 Enrichr
Curr Protoc. 2021 Mar;1(3):e90. doi: 10.1002/cpz1.90.
8
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.一项仅针对病例的研究,旨在确定BRCA1/BRCA2突变携带者患乳腺癌风险的基因修饰因子。
Nat Commun. 2021 Feb 17;12(1):1078. doi: 10.1038/s41467-020-20496-3.
9
Ensembl 2021.Ensembl 2021.
Nucleic Acids Res. 2021 Jan 8;49(D1):D884-D891. doi: 10.1093/nar/gkaa942.
10
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.遗传性乳腺癌和卵巢癌 (HBOC):其分子特征、筛查、治疗和预后的综述。
Breast Cancer. 2021 Nov;28(6):1167-1180. doi: 10.1007/s12282-020-01148-2. Epub 2020 Aug 29.